// App-Quantinova.ai

: Prognostic Value of a New Clinically-Based Classification System in Patients with CMML Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis of the EBMT Chronic Malignancies Working Party

Researchers

Presenter

  • Francesco Onida

Principal Investigators

  • Linda Koster

  • Simona Iacobelli

  • Peter Dreger

  • Martin Bornhuser

  • Nicolaus Krger

  • Jorge Sierra

  • Grard Soci

  • Jan J Cornelissen

  • Xavier Poire

  • Edgar Faber

  • Jean-Henri Bourhis

  • Jrgen Finke

  • Jakob R. Passweg

  • Urpu Salmenniemi

  • Harry C. Schouten

  • Yves Beguin

  • Sonja Martin

  • Eric Deconinck

  • Arnold Ganser

  • Samo Zver

  • Bruno Lioure

  • Nigel H. Russell

  • Marie Robin

  • Ibrahim Yakoub-Agha

Medical Centers

  • Endocrinology Unit, Foundation IRCCS CaÂ’ Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy

  • University of Rome Tor Vergata, Rome, Italy

  • EBMT Data Office Leiden,, Leiden,, Netherlands

  • Dept. of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany

  • Department of Hematology/Oncology, Medical Clinic and Policlinic,University Hospital Carl Gustav Carus Dresden, Technical University Dresden,Dresden,Germany

  • Department of Stem Cell Transplantation, University Medical Center Hamburg, Hamburg,

  • Oncology Department, Hospital de la Santa Creu i Sant Pau and Universitat Autonoma de Barcelona, Barcelona, Spain

  • Department of Hematology and Transplantation Unit, APHP Saint Louis Hospital, Paris, France

  • Erasmus Medical Center Cancer Institute, Rotterdam, Netherlands

  • Division of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium

  • Department of Hemato-Oncology,University Hospital Olomouc and Faculty of Medicine and Dentistr

  • Department of Surgery, Gustave Roussy Cancer Centre, Villejuif, France

  • Department of Hematology, Oncology and Stem Cell Transplantation, Uniklinik Freiburg, Freiburg, Germany

  • Haematology, University Hospital, Basel, Switzerland

  • Turku University Hospital, Turku, Finland

  • Department of Internal Medicine, Academic Hospital Maastricht, Maastricht, Netherlands

  • Laboratory of Hematology, University of Liege, Liege, Belgium

  • Department of Hematology and Oncology, Katharinenhospital, Stuttgart, Germany

  • Department of Medical Oncology, Besancon University Hospital, Besancon, France

  • Dept. Hematology, Hemostaseology, Oncology & Stem Cell Transplantation, Hannover Medical School, Hannover, Germany

  • Department of Gastroenterology, University Medical Center Ljubljana, Ljubljana, Slovenia

  • Nouvel Hopital Civil, Strasbourg, France

  • Nottingham City Hospital, Nottingham, United Kingdom

  • Hematology/Transplantation, Hospital Saint Louis, Paris, France

  • CHU de Lille, LIRIC, INSERM U995, Université de Lille, France, Lille, France

Locations

  • Italy

  • Netherlands

  • Germany

  • Spain

  • France

  • Belgium

  • Czech Republic

  • Switzerland

  • Slovenia

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic myelomonocytic leukemia

Biomarkers

  • White Blood Cell

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved